top of page
THE VISION

Paradigm shift in anastomotic technique

We innovate, manufacture and deliver

a new generation of surgical instruments

for colorectal surgery

The Vision
HISTORY

2006

The start 2006

CarpoNovum is founded by two colorectal surgeons

Anders Grönberg, MD, PhD, engineer, and Prof. Henrik Thorlacius, MD, PhD

Award 2006

CarpoNovum received

Öhrlings Price Water House Coopers and LUIS Innovation awards

2007

Award 2007

CarpoNovum received the award for the most successful company in the Connect Sweden network

Award 2007

CarpoNovum received the national Skapa Development Award

2011

CE 2011

CARP®, predecessor of C-REX®, received CE marking

Developing 2011-2018

C-REX® device family was developed, clinical studies were conducted in Sweden, Denmark and China.

2018

CE 2018

CE mark is warded to the C-REX® portfolio

2020

Scandinavian CCS 2020

A subsidiary of CarpoNovum AB, is formed for surgical education and clinical practice.

History
ABOUT

CarpoNovum is a Swedish company innovating, manufacturing and delivering a new generation of surgical instruments for colorectal surgery.

 

Company’s headquarters, in-house R&D and manufacturing facilities are located in Halmstad, Sweden.

About
BOARD OF DIRECTORS
Board of directors

Thomas Enckell, Attorney-at-law

Chairman of the Board

Thomas Enckell, chairman of the board, is a lawyer specialized in corporate and real estate law and transactions. He is a member of the Swedish Bar Association and has more than 20 years of experience in M&A and legal issues related to corporate governance. He acts as legal advisor to funds, private equity players and other private companies. Worked at several major Swedish law firms and is founder of Enckell Law Firm. Thomas is board member in a couple of companies in different business areas. 

enkell.png

Ulf Jungnelius

Member of the Board

Trained as an MD and has previously held leading roles in oncology and clinical development at the pharmaceutical companies Celgene, Takeda, Pfizer, and Eli Lilly. Jarl Jungnelius is currently the CEO of Isofol Medical AB.

jarl.png

Ingrid Atteryd-Heiman

Member of the Board

She has been active in the Life Science industry since 2012 with board work, both as chairman and member. She is currently a member of companies with drug development and medical technology development. She has a degree in economics from Lund University and an MBA in international business from Uppsala University.

ingrid.png

Tommy Hedberg

Member of the Board

Senior Advisor in a number of life science companies. Tommy has extensive experience in international marketing and sales, clinical development, and product development in pharmaceuticals and medical technology companies such as Atos Medical, Medscand AB and Janssen Pharma AB. Tommy was the CEO of Atos Medical for 17 years.

tommy.png

Jonas Gulliksson

Member of the Board

Member of the Swedish and US Bar Associations, European Patent Attorney. Founder of the patent law firm Ström & Gulliksson and the law firm Advokatfirman Gulliksson. Former president of Licensing Executives Society International with extensive knowledge in business law, technology transfer agreements, and intellectual property prosecution. Jonas has almost 50 years of experience in national and international patent and intellectual property litigation and arbitration.

jonas.png
CLINICAL ADVISORY BOARD
Board of Advisors

Gunnar Németh, prof.

Clinical advisor

M.D. and professor of orthopedic surgery. Former head of the department for orthopedic surgery at Karolinska Institutet, and acting subject specialist at Region Stockholm. In 2007 he became CEO of Capio S:t Görans Hospital, and the year after that CEO of the Capio Group. Since 2011 he has been senior advisor for several companies. 

gunnar_nemeth.webp

Torbjörn Holm, prof.

Clinical advisor

Former surgical professor at Karolinska Institutet, specialising in colorectal surgery. He has brought significant contributions to the  development of the multidisciplinary treatment of colorectal cancer in Sweden. 

torbjorn_holm.webp

Roger Henriksson, prof.

Clinical advisor

Professor and senior oncologist at Norrland's University Hospital. Former leader of the regional Cancer Centrum Stockholm Gotland, and of Stockholms oncological clinic, including Radiumhemmet at Karolinska University Hospital. Furthermore, Mr. Henriksson has also been chairman of the expert panel advising Stockholm's medicinal committee.

roger henriksson.webp

Björn Zackrisson, Dr.

Clinical advisor

Medical specialist within general surgery and urology. Former director of Skånevård, including the hospitals of Ängelholm, Helsingborg, Landskrona and Trelleborg as well as Psychiatry Skåne. Former board member of Tiohundra AB in Norrtälje, Innovation Skåne and the Swedish Medical Association Leadership Group. He has also held leading positions at Capio, Praktikertjänst and Team Olivia.

Björn Z.jpeg

Ulf Jungnelius, Dr.

Clinical advisor

Trained as an MD and has previously held leading roles in oncology and clinical development at the pharmaceutical companies Celgene, Takeda, Pfizer, and Eli Lilly. Jarl Jungnelius is CEO of Isofol Medical AB, and is also a member of the board of directors of CarpoNovum AB.

jarl.png
SURGICAL ADVISORY BOARD

Niels Qvist, prof.

Surgical advisor

Became a surgeon in 1988 and is now Head of Research at the unit for Gastroenterology Surgery at Odense University Hospital. He has published over 300 peer reviewed medical journals and holds big international network. In 2021 he obtained ethical approval for a clinical trial on the CarpoNovum C-REX in Denmark, which is currently being set up.

Niels Qvist.jpg

Torbjörn Holm, prof.

Surgical advisor

Former surgical professor at Karolinska Institutet, specialising in colorectal surgery. He has brought significant contributions to the  development of the multidisciplinary treatment of colorectal cancer in Sweden. 

torbjorn_holm.webp

André D'Hoore, prof. 

Surgical advisor

Started as a surgeon in 1994 and is now one of Europe's leading surgeons with a big international network and post doc training at leading clinics such as Cleveland Clinic in Fort Lauderdale, St Mark's Hospital in London and the Hôpital Cantonal in Geneva. Experienced in handling new medical technologies and publishing studies. His clinical work has resulted in over 160 peer reviewed articles. 

Prof Andrè D`Hoore.jpg
FINANCIAL ADVISORY BOARD

Johan Stein

Financial advisor

Lecturer and researcher at Stockholm School of Economics for 10 years. He gained a doctorate degree in 2011, later named docent and professor. Has been Head of research and portfolio manager at a number of hedge funds and with Nordea Investment Management. Also has experience from Alfred Berg and BNP Paribas.

johan-stein.jpg

Christophe Genetay

Financial advisor

M.Sc. Civ Eng. and has 25 years experience in the financial industry, working with listed and non-listed companies. Former head of training at the Swedish Council for small investors. Since 2013 been engaged with Investor Relations across various industries.

christophe.jpg
Q&R

Quality and Regulatory

C-REX® devices are CE-marked in Europe. Regulatory approval has been achieved by complying with Medical Device Directive 93/42/EC as Class IIa devices and CarpoNovum holds a certificate of current version of EN ISO 13485.

Quality policy

All team members of CarpoNovum are committed to improve lives of people undergoing colorectal surgery, by providing high-quality, safe and effective products and services that meet our customers’ needs, with focus on continual improvement, by:
 

  • having a close collaboration with leading surgeons and health care professionals

  • complying with all applicable regulatory requirements

  • continually improving the effectiveness of our Quality Management System

  • periodically reviewing the performance of the Quality Management System and our Quality Objectives

  • communicating this Quality Policy to all team members, subcontractors and suppliers to assure that it is understood and implemented


 

Quality & Regulatory
bottom of page